<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1130-6343</journal-id>
<journal-title><![CDATA[Farmacia Hospitalaria]]></journal-title>
<abbrev-journal-title><![CDATA[Farm Hosp.]]></abbrev-journal-title>
<issn>1130-6343</issn>
<publisher>
<publisher-name><![CDATA[Grupo Aula Médica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1130-63432022000300007</article-id>
<article-id pub-id-type="doi">10.7399/fh.13039</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Use of tracking drugs for the search of intra-hospital adverse reactions: a pharmacovigilance study]]></article-title>
<article-title xml:lang="es"><![CDATA[Uso de fármacos alertantes para la detección de reacciones adversas intrahospitalarias: estudio de farmacovigilancia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Corrêa-Benedet-Baesso]]></surname>
<given-names><![CDATA[Kely]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zapelini-do Nascimento]]></surname>
<given-names><![CDATA[Diego]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[de Sá-Soares]]></surname>
<given-names><![CDATA[Alessandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Schuelter-Trevisol]]></surname>
<given-names><![CDATA[Fabiana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidade do Sul de Santa Catarina Curso de Medicina ]]></institution>
<addr-line><![CDATA[Tubarão Santa Catarina]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade do Sul de Santa Catarina Programa de Pós-Graduação em Ciências da Saúde ]]></institution>
<addr-line><![CDATA[Tubarão Santa Catarina]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Nossa Senhora da Conceição Centro de Pesquisas Clínicas ]]></institution>
<addr-line><![CDATA[Tubarão Santa Catarina]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>46</volume>
<numero>3</numero>
<fpage>146</fpage>
<lpage>151</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-63432022000300007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1130-63432022000300007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1130-63432022000300007&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: To estimate the incidence of potential in-hospital adverse reactions with the use of alert drugs in a general hospital in southern Brazil.  Method: Cross-sectional study, carried out in a hospital in southern Brazil. The electronic medical records (TASY®) of patients hospitalized between January and August 2020, who were prescribed one of the drugs earmarked for tracking adverse drug reactions, were evaluated: the drugs included flumazenil, fexofenadine hydrochloride, naloxone, promethazine, diphenhydramine and loperamide.  Results: A total of 13,476 medical records were reviewed and 204 (1.5%) were included in the study in which tracker use was indicated in the management of adverse drug reactions. In this study a total of 18 different signs or symptoms were found in medical records, with pruritus/hyperemia/urticaria being the most reported symptoms (n = 76). Among the drug classes that caused most adverse drug reactions, opioids were the most mentioned (n = 44). It should be noted that in 49 medical records the information on which drug caused the adverse events was not reported. Regarding the cause of hospitalization of patients who used screening drugs, cancer was the most frequent (n = 37).  Conclusions: This study indicates that the use of trackers can be a tool to estimate the occurrence of adverse drug reactions and to establish adverse events related to the use of medications, which should be reported to the pharmacovigilance service, with a view to patient safety.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Estimar la incidencia de potenciales reacciones adversas intrahospitalarias con el uso de prescripciones alertantes en un hospital general del sur de Brasil.  Método: Estudio transversal, realizado en un hospital del sur de Brasil. Se evaluaron las historias clínicas electrónicas (TASY®) de los pacientes hospitalizados entre enero y agosto de 2020, a los que se les prescribió uno de los medicamentos destinados al seguimiento de reacciones adversas a medicamentos: los medicamentos incluían flumazenil, clorhidrato de fexofenadina, naloxona, prometazina, difenhidramina y loperamida.  Resultados: Se revisaron 13.476 historias clínicas y se incluyeron 204 (1,5%) en el estudio en el que se indicó el uso de prescripciones alertantes en el manejo de reacciones adversas a medicamentos. En este estudio se encontró un total de 18 signos o síntomas diferentes en las historias clínicas, siendo el prurito, la hiperemia y la urticaria los síntomas más reportados (n = 76). Entre las clases de fármacos que causaron la mayoría de las reacciones adversas a medicamentos, los opioides fueron los más mencionados (n = 44). Cabe señalar que en 49 historias clínicas no se reportó la información sobre qué fármaco causó los eventos adversos. En cuanto a la causa de hospitalización de los pacientes que utilizaron prescripciones alertantes, el cáncer fue la más frecuente (n = 37).  Conclusiones: Este estudio indica que el uso de alertadores puede ser una herramienta para estimar la incidencia de reacciones adversas a medicamentos y establecer eventos adversos relacionados con el uso de medicamentos, los cuales deben ser reportados al servicio de farmacovigilancia, con miras a la seguridad del paciente.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Drug-Related Side Effects and Adverse Reactions]]></kwd>
<kwd lng="en"><![CDATA[Pharmacy Service, Hospital]]></kwd>
<kwd lng="en"><![CDATA[Drug Utilization]]></kwd>
<kwd lng="en"><![CDATA[Patient Safety]]></kwd>
<kwd lng="en"><![CDATA[Pharmacovigilance]]></kwd>
<kwd lng="es"><![CDATA[Efectos colaterales y reacciones adversas relacionadas con medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Servicio de Farmacia, utilización de medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Seguridad del paciente]]></kwd>
<kwd lng="es"><![CDATA[Farmacovigilancia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lombardo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Eserian]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A análise da qualidade de medicamentos e o papel do laboratório oficial no contexto da saúde pública]]></article-title>
<source><![CDATA[Re. Adm Saúde]]></source>
<year>2017</year>
<volume>17</volume>
<numero>67</numero>
<issue>67</issue>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[SCM]]></given-names>
</name>
<name>
<surname><![CDATA[Stipp]]></surname>
<given-names><![CDATA[MAC]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[FT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse events and safety in nursing care]]></article-title>
<source><![CDATA[Rev Bras Enferm]]></source>
<year>2015</year>
<volume>68</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>136-46</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Tajir]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[WN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology, comparative methods of detection, and preventability of adverse drug events]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2005</year>
<volume>39</volume>
<numero>7-8</numero>
<issue>7-8</issue>
<page-range>1169-74</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mota]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Vigo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kuchenbecker]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reações adversas a medicamentos no sistema de farmacovigilância do Brasil, 2008 a 2013: estudo descritivo]]></article-title>
<source><![CDATA[Cad Saúde Pública]]></source>
<year>2019</year>
<volume>35</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fattinger]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Roos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vergeres]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Holenstein]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kind]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Masche]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine]]></article-title>
<source><![CDATA[Br J Clin Pharmacol]]></source>
<year>2000</year>
<volume>49</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>158-67</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nagai]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[PSK]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[LMO]]></given-names>
</name>
<name>
<surname><![CDATA[Romano-Lieber]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Nagai]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[PSK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de rastreadores para busca de reações adversas a medicamentos como motivo de admissão de idosos em pronto-socorro]]></article-title>
<source><![CDATA[Cien Saude Colet]]></source>
<year>2018</year>
<volume>23</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>3997-4006</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[AMM]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[CPB]]></given-names>
</name>
<name>
<surname><![CDATA[Figueredo]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Barroso]]></surname>
<given-names><![CDATA[SCC]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[MMG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reação adversa a medicamentos como fator contribuinte para a internação hospitalar de idosos]]></article-title>
<source><![CDATA[Rev Bras Farm Hosp Serv Saúde]]></source>
<year>2017</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>8-13</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Perdigão]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Erros relacionados aos medicamentos]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Segurança do Paciente: criando organizações de saúde seguras]]></source>
<year>2019</year>
<page-range>161-88</page-range><publisher-loc><![CDATA[Río de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[FIOCRUZ]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Vieira]]></surname>
<given-names><![CDATA[JML]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[ICCR]]></given-names>
</name>
<name>
<surname><![CDATA[Cabral]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Suspected adverse drug reactions reported for Brazilian children: cross-sectional study]]></article-title>
<source><![CDATA[J Pediatr]]></source>
<year>2019</year>
<volume>95</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>682-8</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Flott]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chainani]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Fontana]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Darzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Patient Safety 2030]]></source>
<year>2016</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[NIHR Imperial Patient Safety Translational Research Centre]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leuschle]]></surname>
<given-names><![CDATA[VCKN]]></given-names>
</name>
<name>
<surname><![CDATA[Deuschle]]></surname>
<given-names><![CDATA[RAN]]></given-names>
</name>
<name>
<surname><![CDATA[Leite]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eventos adversos a medicamentos em ambiente hospitalar]]></article-title>
<source><![CDATA[Rev Esp Cien Saúde]]></source>
<year>2016</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>82-91</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Melucci]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rizer]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Prier]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detection of adverse drug events using an electronic trigger tool]]></article-title>
<source><![CDATA[Am J Health Syst Pharm]]></source>
<year>2016</year>
<volume>73</volume>
<numero>17 Suppl 4^sSuppl 4</numero>
<issue>17 Suppl 4^sSuppl 4</issue>
<supplement>Suppl 4</supplement>
<page-range>S112-20</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carnevali]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Krug]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Amant]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Van Pee]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gérard]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[De Béthune]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2013</year>
<volume>47</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1414-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Griffin]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Resar]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
</person-group>
<source><![CDATA[IHI Global Trigger Tool for Measuring Adverse Events]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Institute for Healthcare Improvement]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fabretti]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Brassica]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Cianciarullo]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Romano-Lieber]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rastreadores para a busca ativa de eventos adversos a medicamentos em recém-nascidos]]></article-title>
<source><![CDATA[Cad Saúde Pública]]></source>
<year>2018</year>
<volume>34</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saavedra]]></surname>
<given-names><![CDATA[PAE]]></given-names>
</name>
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[JVL]]></given-names>
</name>
<name>
<surname><![CDATA[Areda]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Os rastreadores de eventos adversos a medicamentos se aplicam a pacientes hospitalizados por queimaduras?]]></article-title>
<source><![CDATA[Rev Bras Queimaduras]]></source>
<year>2018</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>20-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steinman]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Lund]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Miao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Boscardin]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kaboli]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population]]></article-title>
<source><![CDATA[Am Geriatr Soc]]></source>
<year>2011</year>
<volume>59</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>615-21</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sales]]></surname>
<given-names><![CDATA[VBS]]></given-names>
</name>
<name>
<surname><![CDATA[Teles Filho]]></surname>
<given-names><![CDATA[AAM]]></given-names>
</name>
<name>
<surname><![CDATA[Verolla]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Morais]]></surname>
<given-names><![CDATA[BAS]]></given-names>
</name>
<name>
<surname><![CDATA[Diniz]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Iachinski]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anafilaxia: diagnóstico e tratamento]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Carvalho Júnior]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
</person-group>
<source><![CDATA[Alergia e Imunologia: abordagens clínicas e prevenções]]></source>
<year></year>
<page-range>186-99</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giordani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rozenfeld]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[DFM]]></given-names>
</name>
<name>
<surname><![CDATA[Versa]]></surname>
<given-names><![CDATA[GLGS]]></given-names>
</name>
<name>
<surname><![CDATA[Terencio]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Caldeira]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vigilância de eventos adversos a medicamentos em hospitais: aplicação e desempenho de rastreadores]]></article-title>
<source><![CDATA[Rev Bras Epidemiol]]></source>
<year>2012</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>455-67</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rozenfeld]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Giordani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Coelho]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eventos adversos a medicamentos em hospital terciário: estudo piloto com rastreadores]]></article-title>
<source><![CDATA[Rev Saúde Pública]]></source>
<year>2013</year>
<volume>47</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1102-11</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[TJV]]></given-names>
</name>
<name>
<surname><![CDATA[Garbini]]></surname>
<given-names><![CDATA[CAS]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Garbini]]></surname>
<given-names><![CDATA[AJI]]></given-names>
</name>
<name>
<surname><![CDATA[Saliba]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Saliba]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reações adversas a medicamentos entre idosos institucionalizados: prevalência e fatores associados]]></article-title>
<source><![CDATA[Arch Health Invest]]></source>
<year>2017</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>129-35</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nóbrega]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[LBD]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[VP]]></given-names>
</name>
<name>
<surname><![CDATA[Galvão]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicamentos Rastreadores Na Identificação de Reações Adversas em um Hospital]]></article-title>
<source><![CDATA[Rev Bras Farm Hosp Serv Saúde]]></source>
<year>2016</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>42-5</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haile]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Ayen]]></surname>
<given-names><![CDATA[WY]]></given-names>
</name>
<name>
<surname><![CDATA[Tiwari]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India]]></article-title>
<source><![CDATA[Ethiop J Health Sci]]></source>
<year>2013</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>39-48</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Doshi]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Dikshit]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital]]></article-title>
<source><![CDATA[J Pharmacol Pharmacother]]></source>
<year>2012</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>308-13</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[AJR]]></given-names>
</name>
<name>
<surname><![CDATA[Ghidetti]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Macedo]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[Godoy]]></surname>
<given-names><![CDATA[JSR]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[CAB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-pharmacological treatment of arterial hypertension in primary care: An integrative review]]></article-title>
<source><![CDATA[Res Soc Dev]]></source>
<year>2021</year>
<volume>10</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Laguardia]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A segurança do paciente como dimensão da qualidade do cuidado de saúde: um olhar sobre a literatura]]></article-title>
<source><![CDATA[Ciênc Saúde Coletiva]]></source>
<year>2013</year>
<volume>18</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2029-36</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miguel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>2012</year>
<volume>21</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1139-54</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Ricart]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gea-Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Roca-Montañana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gil-Máñez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Feliu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Integrating pharmacovigilance into the routine of pharmacy department: experience of nine years]]></article-title>
<source><![CDATA[Farm Hosp]]></source>
<year>2019</year>
<volume>43</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>128-33</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efecto de la dexmedetomidina y morfina intratecal como coadyuvantes en anestesia obstétrica]]></article-title>
<source><![CDATA[Rev Cient Cienc Méd]]></source>
<year>2020</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>184-91</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Imbeloni]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Naloxona: Estado atual]]></article-title>
<source><![CDATA[Rev Bras Anestesiol]]></source>
<year>1989</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>133-41</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
